The post LINK Price Prediction: Chainlink Eyes $12.50 Recovery After Oversold Signal appeared on BitcoinEthereumNews.com. Peter Zhang Jan 30, 2026 09:41 LINKThe post LINK Price Prediction: Chainlink Eyes $12.50 Recovery After Oversold Signal appeared on BitcoinEthereumNews.com. Peter Zhang Jan 30, 2026 09:41 LINK

LINK Price Prediction: Chainlink Eyes $12.50 Recovery After Oversold Signal

4 min read


Peter Zhang
Jan 30, 2026 09:41

LINK trades at $10.83 with RSI at 29.66 indicating oversold conditions. Technical analysis suggests potential bounce toward $12.50 resistance with critical support at $10.43.

Short-term target (1 week): $11.80-$12.50
Medium-term forecast (1 month): $11.00-$14.50 range
Bullish breakout level: $12.62 (20-day SMA)
Critical support: $10.43

While specific analyst predictions are limited in recent trading sessions, earlier January 2026 forecasts from blockchain analysts targeted LINK prices between $14.50 and $16.50 by February 2026. According to on-chain data platforms, Chainlink’s current technical positioning suggests a potential reversal from oversold levels.

The lack of fresh institutional commentary reflects the broader market uncertainty, though technical indicators are providing clearer signals for potential price direction in the near term.

Chainlink’s technical picture presents a mixed but potentially bullish setup. The RSI reading of 29.66 places LINK firmly in oversold territory, historically a precursor to price bounces. The daily RSI hasn’t been this low since major accumulation zones earlier in 2025.

The MACD histogram at -0.0000 shows bearish momentum is potentially exhausting, while the price trading at $10.83 sits just above the lower Bollinger Band at $10.72. This Bollinger Band position of 0.0291 indicates LINK is hugging the lower boundary, often a reversal signal.

Key moving averages tell a concerning story with LINK trading below all major SMAs: 7-day at $11.64, 20-day at $12.62, 50-day at $12.75, and significantly below the 200-day SMA at $17.45. However, the proximity to the 20-day SMA suggests a potential test of this level on any recovery bounce.

The Average True Range of $0.59 indicates moderate volatility, providing opportunity for swing traders while the 24-hour volume of $58.13 million shows adequate liquidity for position entries and exits.

Bullish Scenario

If LINK can hold current support levels, the primary target becomes the immediate resistance at $11.42, followed by the stronger resistance at $12.01. A break above the 20-day SMA at $12.62 would signal a more substantial recovery toward the upper Bollinger Band at $14.53.

The technical confirmation needed includes RSI moving back above 40, MACD histogram turning positive, and sustained volume above the recent average. This Chainlink forecast assumes broader crypto market stability and no major negative news flow.

Bearish Scenario

Failure to hold the immediate support at $10.43 opens the door to the strong support at $10.03. A break below this level could trigger algorithmic selling toward the $9.50-$9.80 range, representing a 12-15% decline from current levels.

Risk factors include continued macro headwinds, broader DeFi sector weakness, or technical breakdown below the lower Bollinger Band with high volume confirmation.

Should You Buy LINK? Entry Strategy

The current LINK price prediction suggests a tactical buying opportunity for risk-tolerant traders. Consider scaling into positions between $10.70-$10.90, with initial stop-loss below $10.35 to limit downside exposure.

A more conservative approach involves waiting for RSI to exceed 35 and price to reclaim the $11.42 resistance before establishing positions. This reduces downside risk but may sacrifice some upside potential.

Position sizing should account for the 24-hour trading range volatility, with risk management targeting no more than 2-3% portfolio exposure on initial entries.

Conclusion

This LINK price prediction anticipates a 10-15% bounce toward $12.00-$12.50 over the next 7-14 days, supported by oversold technical conditions and proximity to key support levels. The medium-term Chainlink forecast remains cautiously optimistic, though macro conditions warrant careful position management.

Cryptocurrency price predictions are inherently speculative and subject to high volatility. This analysis is for informational purposes only and should not be considered financial advice. Always conduct your own research and consider your risk tolerance before making investment decisions.

Image source: Shutterstock

Source: https://blockchain.news/news/20260130-price-prediction-link-chainlink-eyes-1250-recovery-after-oversold

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump swears he'll donate winnings in $10 billion lawsuit against his own IRS

Trump swears he'll donate winnings in $10 billion lawsuit against his own IRS

President Donald Trump told NBC News' Tom Llamas in an interview released on Wednesday that he has no interest in actually keeping any money he wins from his lawsuit
Share
Rawstory2026/02/05 10:43
US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike

US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike

The post US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike appeared on BitcoinEthereumNews.com. US President Donald Trump said that
Share
BitcoinEthereumNews2026/02/05 10:23
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11